J. Loza

IL-2- or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients

M. Roberti, M. Bianchini, E. Levy, 2012, Breast Cancer Research and Treatment.

High Histologic Grade and High Ki-67 Expression Predict Phenotypic Alterations in Node Metastasis in Primary Breast Cancers

M. Rizzo, Mora Amat, J. Loza, 2017, Journal of breast cancer.

Overexpression of CD85j in TNBC patients inhibits Cetuximab‐mediated NK‐cell ADCC but can be restored with CD85j functional blockade

M. Roberti, E. Levy, J. Mordoh, 2015, European journal of immunology.

Predictive Factors for Non-Sentinel Lymph Node Metastasis in Patients with ACOSOG Z0011 Criteria

R. Chacón, J. Loza, F. Coló, 2018, Breast Care.

Axillary recurrence after sentinel node biopsy for operable breast cancer.

R. Chacón, J. Loza, F. Coló, 2002, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Breast Cancer in Young Women Presents With More Aggressive Pathologic Characteristics: Retrospective Analysis From an Argentine National Database

M. Rizzo, R. Chacón, D. Mysler, 2020, JCO global oncology.

DNA synthesis in estrogen receptor‐positive human breast cancer takes place preferentially in estrogen receptor‐negative cells

C. Ballaré, J. Mordoh, J. Loza, 1989, Cancer.